Latest News

Filters

Filter by tags: Russia CANDU reactor Clear all tag filters

37 news articles found


The director of the Jordan Atomic Energy Commission (JAEC) Khaled Touqan, said, looking forward to the next 10 years, JAEC is considering small reactors. It is looking at various possibilities including designs from Russia, Korea, France, and the UK, trying to determine the optimal technical specifications and how to adapt such reactors to the Jordanian environment, Touqan explained. He noted the potential use of small nuclear reactors for water desalination as well as power production.

Date: Saturday, 29 April 2023
Original article: neimagazine.com/news/newsjordan-considers-floating-npps-10798331

Advances in emerging field of ‘theranostics’ are a game-changer Millions of patients around the globe rely on the regular and timely production of diagnostic and therapeutic isotopes produced in research reactors and accelerator facilities. Image courtesy IAEA. Advances in medical isotope diagnostics and therapy are holding promise for cancer patients, despite challenges facing the nuclear medical field in recent years related to radionuclide production and supply, rising costs, and stricter regulation.

Medical isotopes are radioactive substances used in various diagnostic and therapeutic procedures to treat various types of cancers and other conditions. They are essential for modern medicine, allowing physicians to visualise and target specific organs, tissues and cells in a patient’s body.

Over more than a decade, personalised medicine using nuclear techniques has been gaining pace, allowing doctors to tailor therapies and treatments to the specific needs and physiology of a patient, and to avoid harm to healthy organs or tissues.

According to Sven Van den Berghe, chief executive of Belgium-based isotope producer PanTera, one technique that has seen significant advances is known as theranostics – the term used to describe the combination of using one radioactive drug to diagnose and a second to deliver therapy to treat the main tumour and any metastatic tumours.

Date: Friday, 14 April 2023
Original article: nucnet.org/news/sector-aims-to-tackle-isotope-supply-problems-as-excitement-grows-over-targeted-therapies-4-4-2023

The production of cobalt-60 is critical to healthcare and, with demand soaring, the challenge is to expand supply, writes Martin Comben from the International Irradiation Association.

Date: Wednesday, 29 March 2023
Original article: world-nuclear-news.org/Articles/The-critical-production-of-cobalt-60-in-nuclear-re

In a wide ranging interview for the World Nuclear News podcast, Cameco CEO Tim Gitzel explained: Why the time was right for the Westinghouse deal How Russia's war with Ukraine has led to 'bifurcation' of the nuclear sector Explained Cameco's long-term strategy Looks ahead at the impact of new technologies, including SMRs How nuclear will need to play a key role in getting to net-zero

Date: Wednesday, 09 November 2022
Original article: world-nuclear-news.org/Articles/In-Quotes-Cameco-s-Tim-Gitzel-WNN-podcast-on-nucle

Cameco Corporation and Brookfield Renewable Partners, together with its institutional partners (the consortium), are forming a strategic partnership to acquire Westinghouse Electric Company. Brookfield Renewable, with its institutional partners, will own a 51% interest in Westinghouse and Cameco will own 49%.

Date: Friday, 14 October 2022
Original article: neimagazine.com/news/newscameco-and-brookfield-renewable-to-acquire-westinghouse-10084610

A Memorandum of Understanding (MoU) between Framatome and Exelon Generation will see the two companies work towards the production of cobalt-60 (Co-60) in pressurised water reactors (PWRs) for medical and industrial uses.

Date: Thursday, 06 January 2022
Original article: world-nuclear-news.org/Articles/Framatome-and-Exelon-to-explore-Co-60-production